Allurion Technologies Inc. focuses on ending obesity with a weight loss platform to treat people who are overweight. Its platform, the Allurion Program, features swallowable and procedure-less intragastric balloon for weight loss (the Allurion Balloon) and offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion Virtual Care Suite. The company is headquartered in Natick, Massachusetts.
Stock data | 2024 | Change |
---|---|---|
Price | $0.641 | N/A |
Market Cap | $30.43M | N/A |
Shares Outstanding | 47.47M | N/A |
Employees | 268.00 | N/A |